----

----

| Texas                                                          |   | 59-2219994                              |
|----------------------------------------------------------------|--------|-----------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification Number) |

| Large accelerated filer | o | Non-accelerated filer     | o      |
|-------------------------|---|---------------------------|--------|
| Accelerated filer       | o | Smaller reporting company | þ |

----

----

----

WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES

| PART I – FINANCIAL INFORMATION |                                                                                                                |   |   |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------|--------|--------|
|                                 |                                                                                                                |   |   |   |
| ITEM 1.                              | Management’s Discussion and Analysis of Financial Condition and Results of Operations                         |   |   | 3 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 2.                              | Financial Statements                                                                                                |   |   | 7 |   |
|                                 |                                                                                                                |   |   |   |   |
|                                 | Condensed Consolidated Balance Sheets as of June 30, 2013 (Unaudited) and December 31, 2012                         |   |   | 7 |   |
|                                 |                                                                                                                |   |   |   |   |
|                                 | Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2013 and 2012 |   |   | 8 |   |
|                                 |                                                                                                                |   |   |   |   |
|                                 | Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012           |   |   | 9 |   |
|                                 |                                                                                                                |   |   |   |   |
|                                 | Notes to Unaudited Condensed Consolidated Financial Statements                                                      |   |   | 10 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 3.                              | Quantitative and Qualitative Disclosures about Market Risk                                                          |   |   | 24 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 4.                              | Controls and Procedures                                                                                             |   |   | 24 |   |
|                                 |                                                                                                                |   |   |   |   |
| PART II – OTHER INFORMATION    |                                                                                                                |   |   |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 1.                              | Legal Proceedings                                                                                                   |   |   | 25 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 1A.                             | Risk Factors                                                                                                        |   |   | 26 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 2.                              | Unregistered Sales of Equity Securities and Use of Proceeds                                                         |   |   | 26 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 3.                              | Defaults upon Senior Securities                                                                                     |   |   | 27 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 4.                              | Mine Safety Disclosures                                                                                             |   |   | 27 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 5.                              | Other Information                                                                                                   |   |   | 27 |   |
|                                 |                                                                                                                |   |   |   |   |
| ITEM 6.                              | Exhibits                                                                                                            |   |   | 28 |   |
|                                 |                                                                                                                |   |   |   |   |
| Signatures                           |                                                                                                                |   | 29     |   |

----

Back to Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

----

Back to Table of Contents

----

Back to Table of Contents

----

Back to Table of Contents

----

Back to Table of Contents

ITEM

| WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES |
|------------------------------------------------------|
| CONDENSED CONSOLIDATED BALANCE SHEETS                |
| JUNE 30, 2013 (UNAUDITED) AND DECEMBER 31, 2012      |

----

| ASSETS                                                                                                                                                                                                 |   | June 30, 2013 |        |   | December 31, 2012 |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|-------------|--------|-------------------|--------|
|                                                                                                                                                                                                   |   |          |        |   |              |   |
| CURRENT ASSETS:                                                                                                                                                                                        |   |          |        |   |              |   |
| Cash                                                                                                                                                                                                   |   | $             | 136,307     |   |              | $      | 45,861 |   |
| Accounts Receivable, net                                                                                                                                                                               |   |          | 210,339     |   |              |   | 203,967 |   |
| Inventory, net                                                                                                                                                                                         |   |          | 295,746     |   |              |   | 454,211 |   |
| Employee Advances                                                                                                                                                                                      |   |          | 31,729      |   |              |   | 11,832 |   |
| Notes Receivable - Related Parties, net                                                                                                                                                                |   |          | -           |   |              |   | - |   |
| Accrued Interest - Related Parties, net                                                                                                                                                                |   |          | -           |   |              |   | - |   |
| Deferred Loan Costs                                                                                                                                                                                    |   |          | 6,493       |   |              |   | 7,400 |   |
| Deferred Compensation                                                                                                                                                                                  |   |          | 292,650     |   |              |   | 309,450 |   |
| Prepaid and Other Assets                                                                                                                                                                               |   |          | 79,833      |   |              |   | 11,306 |   |
| Total Current Assets                                                                                                                                                                                   |   |          | 1,053,097   |   |              |   | 1,044,027 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| LONG-TERM ASSETS:                                                                                                                                                                                      |   |          |        |   |              |   |   |   |
| Property and Equipment, net                                                                                                                                                                            |   |          | -           |   |              |   | - |   |
| Intangible Assets, net                                                                                                                                                                                 |   |          | 318,944     |   |              |   | 344,459 |   |
| Deferred Loan Costs                                                                                                                                                                                    |   |          | 1,979       |   |              |   | 5,126 |   |
| Note Receivable, net                                                                                                                                                                                   |   |          | -           |   |              |   | - |   |
| Accrued Interest, net                                                                                                                                                                                  |   |          | -           |   |              |   | - |   |
| Total Long-Term Assets                                                                                                                                                                                 |   |          | 320,923     |   |              |   | 349,585 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| TOTAL ASSETS                                                                                                                                                                                           |   | $             | 1,374,020   |   |              | $      | 1,393,612 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                                                                                                                                                         |   |          |        |   |              |   |   |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| CURRENT LIABILITIES:                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| Accounts Payable                                                                                                                                                                                       |   | $             | 206,213     |   |              | $      | 205,206 |   |
| Accrued Royalties                                                                                                                                                                                      |   |          | 187,500     |   |              |   | 803,238 |   |
| Accrued Liabilities                                                                                                                                                                                    |   |          | 80,929      |   |              |   | 263,165 |   |
| Accrued Interest - Related Parties                                                                                                                                                                     |   |          | 58,927      |   |              |   | 34,054 |   |
| Accrued Interest                                                                                                                                                                                       |   |          | 257,167     |   |              |   | 132,018 |   |
| Derivative Liabilities                                                                                                                                                                                 |   |          | 1,225,776   |   |              |   | 1,336,574 |   |
| Notes Payable - Related Parties                                                                                                                                                                        |   |          | 415,620     |   |              |   | 415,620 |   |
| Notes Payable, net of discount                                                                                                                                                                         |   |          | 2,306,934   |   |              |   | 1,814,287 |   |
| Stock Subscription Payable                                                                                                                                                                             |   |          | 571,500     |   |              |   | 6,000 |   |
| Total Current Liabilities                                                                                                                                                                              |   |          | 5,310,566   |   |              |   | 5,010,162 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| LONG-TERM LIABILITIES                                                                                                                                                                                  |   |          |        |   |              |   |   |   |
| Notes Payable, net of discount                                                                                                                                                                         |   |          | -           |   |              |   | - |   |
| Debentures,net of discount                                                                                                                                                                             |   |          | 142,652     |   |              |   | 189,256 |   |
| Total Long-Term Liabilities                                                                                                                                                                            |   |          | 142,652     |   |              |   | 189,256 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| TOTAL LIABILITIES                                                                                                                                                                                      |   | $             | 5,453,218   |   |              | $      | 5,199,418 |   |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| STOCKHOLDERS' EQUITY (DEFICIT)                                                                                                                                                                         |   |          |        |   |              |   |   |   |
| Preferred Stock, $10 par value, 5,000,000 shares authorized:                                                                                                                                           |   |          | -           |   |              |   | - |   |
| 51,000 designated Series A Preferred Stock, $10 par; 0 issued and outstanding                                                                                                                          |   |          | -           |   |              |   | - |   |
| 7,500 designated Series B Preferred Stock, $10 par; value: 0 issued and outstanding                                                                                                                    |   |          | -           |   |              |   | - |   |
| Common Stock: $.001 par value; 100,000,000 shares authorized; 78,250,752 issued and78,246,663 outstanding as of June 30, 2013 and 68,782,470 issued and 68,778,381 outstanding as of December 31, 2012 |   |          | 78,251      |   |              |   | 68,782 |   |
| Additional Paid-in Capital                                                                                                                                                                             |   |          | 35,846,476  |   |              |   | 35,154,736 |   |
| Treasury Stock                                                                                                                                                                                         |   |          | (12,039     | )      |              |   | (12,039 | ) |
| Accumulated Deficit                                                                                                                                                                                    |   |          | (39,991,886 | )      |              |   | (39,017,285 | ) |
| Total Stockholders' Equity (Deficit)                                                                                                                                                                   |   |          | (4,079,198  | )      |              |   | (3,805,806 | ) |
|                                                                                                                                                                                                   |   |          |        |   |              |   |   |   |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                                                                                             |   | $             | 1,374,020   |   |              | $      | 1,393,612 |   |

----

Back to Table of Contents

| WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES      |
|-----------------------------------------------------------|
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2013 AND 2012 |

----

|                                                 |   | THREE MONTHS |       |   | THREE MONTHS |   |       | SIX MONTHS   |   |   | SIX MONTHS   |   |
|------------------------------------------------------|--------|--------------|------------|--------|--------------|--------|------------|--------------|--------|--------|--------------|--------|
|                                                 |   | ENDED        |       |   | ENDED        |   |       | ENDED        |   |   | ENDED        |   |
|                                                 |   | June 30,2013 |       |   | June 30,2012 |   |       | June 30,2013 |   |   | June 30,2012 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |
| REVENUES                                             |   | $            | 415,693    |   |         | $      | 269,813    |         |   |   | 790,417      |   |   | $ | 373,946 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| COST OF GOODS SOLD                                   |   |         | 229,695    |   |         |   | 193,608    |         |   |   | 444,785      |   |   |   | 311,947 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| GROSS PROFIT                                         |   |         | 185,998    |   |         |   | 76,205     |         |   |   | 345,632      |   |   |   | 61,999 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| GENERAL AND ADMINISTRATIVE EXPENSES:                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| General and Administrative Expenses                  |   |         | 446,798    |   |         |   | 367,427    |         |   |   | 974,727      |   |   |   | 1,832,369 |   |
| Depreciation / Amortization                          |   |         | 12,758     |   |         |   | 16,138     |         |   |   | 25,515       |   |   |   | 32,276 |   |
| Bad Debt Expense                                     |   |         | 2,049      |   |         |   | 48,123     |         |   |   | 5,710        |   |   |   | 81,410 |   |
| INCOME (LOSS) FROM CONTINUING OPERATIONS:            |   |         | (275,607   | )      |         |   | (355,483   | )            |   |   | (660,320     | )      |   |   | (1,884,056 | ) |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| OTHER INCOME (EXPENSES):                             |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| Gain (Loss) on Debt Settlement                       |   |         | (15,350    | )      |         |   | -          |         |   |   | 151,792      |   |   |   | (10,324 | ) |
| Change in fair value of Derivative Liability         |   |         | 495,678    |   |         |   | 620,102    |         |   |   | (82,128      | )      |   |   | 2,672,353 |   |
| Interest Income                                      |   |         | -          |   |         |   | 38,887     |         |   |   | -            |   |   |   | 86,762 |   |
| Interest Expense                                     |   |         | (91,918    | )      |         |   | (55,239    | )            |   |   | (170,008     | )      |   |   | (101,027 | ) |
| Debt related Expense                                 |   |         | (145,139   | )      |         |   | (277,917   | )            |   |   | (213,937     | )      |   |   | (505,853 | ) |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| LOSS BEFORE INCOME TAXES                             |   |         | (32,336    | )      |         |   | (29,650    | )            |   |   | (974,601     | )      |   |   | 257,855 |   |
| Current tax expense                                  |   |         | -          |   |         |   | -          |         |   |   | -            |   |   |   | - |   |
| Deferred tax expense                                 |   |         | -          |   |         |   | -          |         |   |   | -            |   |   |   | - |   |
| NET INCOME (LOSS)                                    |   | $            | (32,336    | )      |         | $      | (29,650    | )            |   |   | (974,601     | )      |   | $ | 257,855 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| Basic and diluted loss per share of common stock     |   | $            | (0.00      | )      |         | $      | (0.00      | )            |   |   | (0.01        | )      |   | $ | 0.00 |   |
|                                                 |   |         |       |   |         |   |       |         |   |   |         |   |   |   |   |   |
| Weighted average number of common shares outstanding |   |         | 72,703,277 |   |         |   | 63,017,092 |         |   |   | 72,993,037   |   |   |   | 60,826,178 |   |

----

Back to Table of Contents

| WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES      |
|-----------------------------------------------------------|
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| FOR THE SIX MONTHS ENDED JUNE 30, 2013 AND 2012           |

----

|                                                                                   |   | 2013   |       |   | 2012   |   |
|----------------------------------------------------------------------------------------|--------|--------|------------|--------|--------|--------|
|                                                                                   |   |   |       |   |   |   |
| Cash flows from operating activities:                                                  |   |   |       |   |   |   |
| Net loss from continuing operations                                                    |   | $      | (974,601   | )      |   | $      | 257,855 |   |
| Adjustments to reconcile net loss to net cash provided (used) in Operating activities: |   |   |       |   |   |   |   |   |
| Depreciation and amortization                                                          |   |   | 25,515     |   |   |   | 32,276 |   |
| Amortization of discounts and deferred costs                                           |   |   | 116,506    |   |   |   | 343,361 |   |
| Stock issued as payment for services                                                   |   |   | 166,750    |   |   |   | - |   |
| Stock issued for debt related costs                                                    |   |   | 5,882      |   |   |   | - |   |
| Warrant expense                                                                        |   |   | 59,350     |   |   |   | 118,000 |   |
| Non-cash debt related costs                                                            |   |   | -          |   |   |   | 55,500 |   |
| Re-acquisition of distributorship                                                      |   |   | -          |   |   |   | 907,872 |   |
| (Gain) loss on fair market value of derivative liabilities                             |   |   | 82,128     |   |   |   | (2,672,353 | ) |
| Loss on debt settlement                                                                |   |   | 40,350     |   |   |   | 10,324 |   |
| Prepayment Expense                                                                     |   |   | -          |   |   |   | (31,638 | ) |
| Changes in assets and liabilities:                                                     |   |   |       |   |   |   |   |   |
| (Increase) decrease in accounts receivable, net                                        |   |   | (6,372     | )      |   |   | (91,251 | ) |
| (Increase) decrease in inventory                                                       |   |   | 158,465    |   |   |   | (16,404 | ) |
| (Increase) decrease in employee advances                                               |   |   | (19,897    | )      |   |   | 22,341 |   |
| (Increase) decrease in accrued interest receivable - related parties                   |   |   | -          |   |   |   | (16,519 | ) |
| (Increase) decrease in accrued interest receivable                                     |   |   | -          |   |   |   | (70,244 | ) |
| (Increase) decrease in prepaids and other assets                                       |   |   | (68,527    | )      |   |   | (12,764 | ) |
| Increase (decrease) in allowance for uncollectible interest                            |   |   | -          |   |   |   | 66,946 |   |
| Increase (decrease) in accrued royalties                                               |   |   | (615,738   | )      |   |   | 187,500 |   |
| Increase (decrease) in accounts payable                                                |   |   | 1,007      |   |   |   | 35,976 |   |
| Increase (decrease) in accrued liabilities                                             |   |   | (182,236   | )      |   |   | (81,237 | ) |
| Increase (decrease) in accrued interest payable - related parties                      |   |   | 24,873     |   |   |   | 8,152 |   |
| Increase (decrease) in accrued interest payable                                        |   |   | 127,899    |   |   |   | 86,447 |   |
| Net cash flows provided (used) in operating activities                                 |   |   | (1,058,646 | )      |   |   | (859,860 | ) |
|                                                                                   |   |   |       |   |   |   |   |   |
| Cash flows from investing activities:                                                  |   |   |       |   |   |   |   |   |
| Purchase of notes receivable - related parties                                         |   |   | -          |   |   |   | - |   |
| Proceeds from notes receivable - related parties                                       |   |   | -          |   |   |   | 371,839 |   |
| Net cash flows used in investing activities                                            |   |   | -          |   |   |   | 371,839 |   |
|                                                                                   |   |   |       |   |   |   |   |   |
| Cash flows from financing activities:                                                  |   |   |       |   |   |   |   |   |
| Net change in bank overdraft                                                           |   |   | -          |   |   |   | 11,913 |   |
| Proceeds from notes payable - related parties                                          |   |   | -          |   |   |   | 315,200 |   |
| Payments on notes payable - related parties                                            |   |   | -          |   |   |   | (21,200 | ) |
| Proceeds from notes payable                                                            |   |   | 739,357    |   |   |   | 391,000 |   |
| Payments on notes payable                                                              |   |   | (165,025   | )      |   |   | (560,000 | ) |
| Proceeds from debentures                                                               |   |   | -          |   |   |   | 347,500 |   |
| Proceeds from sale of stock                                                            |   |   | -          |   |   |   | - |   |
| Proceeds from exercise of warrants                                                     |   |   | 5,760      |   |   |   | - |   |
| Proceeds from stock subscriptions payable                                              |   |   | 569,000    |   |   |   | - |   |
| Net cash flows provided by financing activities                                        |   |   | 1,149,092  |   |   |   | 484,413 |   |
|                                                                                   |   |   |       |   |   |   |   |   |
| Increase (decrease) in cash                                                            |   |   | 90,446     |   |   |   | (3,608 | ) |
|                                                                                   |   |   |       |   |   |   |   |   |
| Cash and cash equivalents, beginning of period                                         |   |   | 45,861     |   |   |   | 3,608 |   |
| Cash and cash equivalents, end of period                                               |   | $      | 136,307    |   |   | $      | - |   |
|                                                                                   |   |   |       |   |   |   |   |   |
| Cash paid during the period for:                                                       |   |   |       |   |   |   |   |   |
| Interest                                                                               |   | $      | 17,236     |   |   | $      | 6,428 |   |
| Income Taxes                                                                           |   |   | -          |   |   |   | - |   |
|                                                                                   |   |   |       |   |   |   |   |   |
| Supplemental non-cash investing and financing activities:                              |   |   |       |   |   |   |   |   |
| Common stock issued for debt conversion                                                |   | $      | 414,388    |   |   | $      | 633,000 |   |
| Common stock issued for services                                                       |   | $      | 166,750    |   |   | $      | - |   |
| Common stock issued for warrants                                                       |   | $      | 76,988     |   |   | $      | - |   |
| Common stock issued for debt related costs                                             |   | $      | 3,382      |   |   | $      | 1,200 |   |

----

Back to Table of Contents

WOUND MANAGEMENT TECHNOLOGIES, INC. AND SUBSIDIARIES

----

----

Back to Table of Contents

----

Back to Table of Contents

----

Back to Table of Contents

| (i) | To refrain from exercising its rights under the Note through October 16, 2012, which date can, at the Company’s option, be extended for two consecutive periods of 30 days each, |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (ii) | To convert $20,000 in principal amount owed under the Note into shares of the Company’s Common Stock, the number of such shares to be determined as set forth in the Forbearance Agreement; and |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (iii) | To accept as payment in full of the Note (in conjunction with the issuance of the Conversion Shares) a cash payment of $200,000 on or before October 16, 2012 (as such date may be extended at the Company’s option). |
|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Back to Table of Contents

| Related party          |   | Nature of relationship                                                                                                                                                |   | Terms of the agreement                                                                 |   | Principal amount |     |   | Accrued interest |   |
|------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------|--------|------------------|----------|--------|------------------|--------|
|                   |   |                                                                                                                                                                  |   |                                                                                   |   |             |     |   |             |   |
| Secure eHealth         |   | Secure eHealth was a 100% owned subsidiary of the Company until December 2011. Scott Haire, former CFO of Wound Management, is the managing member of Secure eHealth. |   | Unsecured line of credit with interest accrued at rate of 1% per annum, due on demand. |   | $                | 293,233  |   |             | $      | 2,232 |   |
|                   |   |                                                                                                                                                                  |   |                                                                                   |   |             |     |   |             |   |   |   |
| Commercial Holding, AG |   | Commercial Holding AG, LLC has provided previous lines of credit to affiliates of WMT.                                                                                |   | Unsecured note with interest accrued at rate of 10% per annum, due on demand.          |   |             | 200,000  |   |             |   | 33,667 |   |
|                   |   |                                                                                                                                                                  |   |                                                                                   |   |             |     |   |             |   |   |   |
|                   |   | Allowance for Doubtful Accounts                                                                                                                                       |   |                                                                                   |   |             | (493,233 | )      |             |   | (35,899 | ) |
|                   |   |                                                                                                                                                                  |   |                                                                                   |   |             |     |   |             |   |   |   |
| TOTAL                  |   |                                                                                                                                                                  |   |                                                                                   |   | $                | 0        |   |             | $      | 0 |   |

| Note receivable |   | Terms of the agreement                                                                              |   | Principal amount |       |   | Accrued interest |   |
|-----------------|--------|-----------------------------------------------------------------------------------------------------|--------|------------------|------------|--------|------------------|--------|
|            |   |                                                                                                |   |             |       |   |             |   |   |   |
| Private Access  |   | Convertible note receivable which accrues interest at 9% per annum, maturity date of July 31, 2013. |   | $                | 1,500,000  |   |             | $      | 548,048 |   |
|            |   | Allowance for Doubtful Accounts                                                                     |   |             | (1,500,000 | )      |             |   | (548,048 | ) |
| Total           |   |                                                                                                |   | $                | 0          |   |             | $      | 0 |   |

----

Back to Table of Contents

| Related party           |   | Nature of relationship                                                       |   | Terms of the agreement                                                                                                                                         |   | Principal amount |    |   | Accrued interest |   |
|-------------------------|--------|------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------|---------|--------|------------------|--------|
|                    |   |                                                                         |   |                                                                                                                                                           |   |             |    |   |             |   |   |   |
| Lutz Investments, LP    |   | Mr. Lutz is the CEO of the Company                                           |   | Convertible note payable due March 31, 2012. The note is convertible at $0.19 per share. As of June 30, 2013, the note has not been converted and is past due. |   | $                | 200,000 |   |             | $      | 23,165 |   |
|                    |   |                                                                         |   |                                                                                                                                                           |   |             |    |   |             |   |   |   |
| Dr. Philip J. Rubinfeld |   | Mr. Rubinfeld is a member of the Board of Directors                          |   | See “Third Quarter 2012 Secured Subordinated Promissory Notes” As of June 30, 2013, $100,000 of this note remains due.                             |   |             | 100,000 |   |             |   | 15,483 |   |
|                    |   |                                                                         |   |                                                                                                                                                           |   |             |    |   |             |   |   |   |
| Araldo A. Cossutta      |   | Mr. Cossutta is a member of the Board of Directors                           |   | See “Third Quarter 2012 Secured Subordinated Promissory Notes” As of June 30, 2013, $75,000 of this note remains due.                              |   |             | 75,000  |   |             |   | 11,612 |   |
|                    |   |                                                                         |   |                                                                                                                                                           |   |             |    |   |             |   |   |   |
| MAH Holding, LLC        |   | MAH Holding, LLC has provided previous lines of credit to affiliates of WMT. |   | Unsecured note with interest accrued at 10% per annum, due on demand.                                                                                          |   |             | 40,620  |   |             |   | 8,667 |   |
|                    |   |                                                                         |   |                                                                                                                                                           |   |             |    |   |             |   |   |   |
| Total                   |   |                                                                         |   |                                                                                                                                                           |   | $                | 415,620 |   |             | $      | 58,927 |   |

----

Back to Table of Contents

| Note payable                                             |   | Terms of the agreement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |   | Principal amount |    |   | Discount |   |   | Principal net of discount |   |   | Accrued interest |   |
|----------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------|---------|--------|----------|--------|--------|---------------------------|--------|--------|------------------|--------|
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| March 4, 2011 Note Payable                               |   | $223,500 note payable; (i) interest accrues at 13% per annum; (ii) maturity date of September 4, 2011; (iii) $20,000 fee due at maturity date with a $1,000 per day fee for each day the principal and interest is late. This note is currently the subject of litigation (see Note 3 “Significant Transactions -"Litigation)                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   | $                | 223,500 |   |     |   | -      |                      |   | $      | 223,500          |   |   | $ | 44,147 |   |
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| Purchase Order Financing Agreement                       |   | $50,000 note payable; (i) interest accrues at 10% per annum; (ii) proceeds used to purchase inventory; (iii) lender will be reimbursed $25 per gram as the inventory is sold. As of June 30, 2013 the lender is due $40,500 of sales proceeds.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |   |             | 38,822  |   |     |   | -      |                      |   |   | 38,822           |   |   |   | 2,797 |   |
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| Third Quarter 2012 Secured Subordinated Promissory Notes |   | Seventeen notes (including two with related parties mentioned above) in the original aggregate principal amount of $1,055,000; (i) 5% interest due on maturity date; (ii) maturity date of October 12, 2012; (iii) after the maturity date interest shall accrue at 18% per annum and the Company shall pay to the note holders, on a pro rata basis, an amount equal to twenty percent of the sales proceeds received by the Company and its subsidiary, WCI, from the sale of surgical powders, until such time as the note amounts have been paid in full. As of June 30, sixteen of these notes remain due in the aggregate principal amount of $1,035,000, of which thirteen are with unrelated parties. Additionally, $78,980 of surgical sales proceeds have not been remitted to the note holders. |   |             | 860,000 |   |     |   | -      |                      |   |   | 860,000          |   |   |   | 133,154 |   |
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| September 19, 2012 Promissory Note                       |   | $20,000 note payable; (i) interest accrues at 10% per annum; (ii) maturity date of December 31, 2012; (iii) warrant to purchase 20,000 shares of common stock at an exercise price of $0.15 per share to be issued upon default. As of December 31, 2012 this note was not paid and the 20,000 warrants were issued to the note holder. As of June 30, 2013, the $20,000 balance is past due.                                                                                                                                                                                                                                                                                                                                                                                                              |   |             | 20,000  |   |     |   | -      |                      |   |   | 20,000           |   |   |   | 1,562 |   |
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| September 28, 2012 Promissory Note                       |   | $51,300 note payable (i) interest accrues at 10% per annum; (ii) maturity date of December 31, 2012; (iii) default interest rate of 15% per annum. As of June 30, 2013, this note is past due.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |   |             | 51,300  |   |     |   | -      |                      |   |   | 51,300           |   |   |   | 5,180 |   |
|                                                     |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |   |             |    |   |     |   |   |                      |   |   |             |   |   |   |   |   |
| June 21, 2011 Note                                       |   | Convertible promissory note in the principal amount of $560,000; (i) interest accrues at 12% per annum; (ii) maturity date of June 21, 2015; (iii) upon closing the Company issued to the lender 100,000 shares of Common Stock valued at $60,000 and two warrants to purchase 250,000 shares of common stock each, with exercise prices of $0.50 $1.00; (iv) the debt is convertible at a 30% discount on the fair market value of the stock. The Company measured the fair value of the warrants and the beneficial conversion feature of the note and recorded a discount against the principal of the note. (see Note 3 "Significant Transaction - Forbearance Agreement")                                                                                                                             |   |             | 200,000 |   |     |   | -      |                      |   |   | 200,000          |   |   |   | - |   |

----

Back to Table of Contents

| March 2012 Convertible Notes          |   | Three convertible notes in the principal amount of $25,000, $50,000 and $100,000 respectively; (i) issued between March 3 and March 22, 2012; (ii) convertible at $0.19 per share; (iii) interest accrues at 5% per annum; (iv) interest accrues at 9% per annum after the due dates between March 31 and June 30, 2012. As of the date of this filing these notes are past due.                                                                                                                                                                                          |   |   | 175,000   |   |   |   | -       |   |   |   | 175,000   |   |   |   | 18,699  |   |
|---------------------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-----------|--------|--------|--------|---------|--------|--------|--------|-----------|--------|--------|--------|---------|--------|
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| Second Quarter 2012 Convertible Notes |   | Two $25,000 notes; (i) issued on April 3 and April 23, respectively; (ii) convertible at $0.19 per share; (iii) interest accrues at 5% per annum; (iv) interest accrues at 9% per annum after the due dates of April 30 and June 30, 2012, respectively. On September 20, 2012, 222,420 shares of Common Stock were issued in conversion of the April 23 note. As of the date of this filing the April 3 note is past due.                                                                                                                                                |   |   | 25,000    |   |   |   | -       |   |   |   | 25,000    |   |   |   | 2,760   |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| May 30, 2012 Convertible Note         |   | Note in the principal amount of up to $275,000 including an approximate original issue discount of 10%; (i) maturity date one year from the effective date (ii) convertible at the lesser of $0.19 or a 30% discount on the fair market value of the Company's common stock; (iv) one time interest charge of 5% will be applied if the note is not repaid within the first 90 days.                                                                                                                                                                                      |   |   | 102,673   |   |   |   | (50,718 | )      |   |   | 51,955    |   |   |   | 2,750   |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| February 19, 2013 Convertible Notes   |   | Two $250,000 promissory notes; (i) due upon the Company’s achievement of certain revenue targets; (ii) interest accrues at 10% per annum (iii) convertible at the option of the holder into shares of the Company’s common stock at a conversion price of $.07 per share, or into an equivalent number of shares of the Company’s Series C Preferred Stock.                                                                                                                                                                                             |   |   | 500,000   |   |   |   | -       |   |   |   | 500,000   |   |   |   | 18,082  |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| May 13, 2013 Promissory Note          |   | Note in the principal amount of up to $142,000; (i) interest accrues at 10% per annum; (ii) proceeds used to purchase inventory; (iii) maturity date of May 13, 2015; (iv) lender will be reimbursed all net revenues collected on inventory purchased with note proceeds on a monthly basis until the note is paid in full.                                                                                                                                                                                                                                              |   |   | 71,357    |   |   |   | -       |   |   |   | 71,357    |   |   |   | 874     |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| June 19, 2013 Promissory Note         |   | $50,000 note payable; (i) interest accrues at 9% per annum; (ii) the principal is due and payable as follows: (a) $5,000 each on August 19, 2013 and September 19, 2013; and (b) $10,000 on October 19 and November 19, 2013 and (c) $20,000 on December 19, 2013, the maturity date; (iii) the Company will issue to Lender a five-year warrant to purchase a total of 225,000 shares of common Stock at a price of $0.09 per share. Additionally, the Company will issue warrants to purchase 375,000 common shares at $0.09 exercisable only upon an event of default. |   |   | 50,000    |   |   |   | -       |   |   |   | 50,000    |   |   |   | 150     |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| June 24, 2013 Promissory Note         |   | $40,000 note payable; (i) interest accrues at 10% per annum; (ii) the principal is due and payable as follows: (a) $5,000 each on July 25, 2013 and August 25, 2013; and (b) $10,000 each on September 25, 2013, October 25, 2013, November 25, 2013(the maturity date); (iii) the Company will issue to Lender a five-year warrant to purchase a total of 175,000 shares of common Stock at a price of $0.09 per share.                                                                                                                                                  |   |   | 40,000    |   |   |   | -       |   |   |   | 40,000    |   |   |   | 78      |   |
|                                  |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |      |   |   |   |    |   |   |   |      |   |   |   |    |   |
| Total                                 |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   | $      | 2,357,652 |   |   | $      | (50,718 | )      |   | $      | 2,306,934 |   |   | $      | 230,233 |   |

----

Back to Table of Contents

----

Back to Table of Contents

|                                                |   | June 30, 2013 |     |   | December 31, 2012 |   |
|-----------------------------------------------------|--------|---------------|----------|--------|-------------------|--------|
|                                                |   |          |     |   |              |   |   |   |
| Patent                                              |   | $             | 510,310  |   |              | $      | 510,310 |   |
| Accumulated amortization                            |   |          | (191,366 | )      |              |   | (165,851 | ) |
| Patent, net of accumulated amortization             |   |          | 318,944  |   |              |   | 344,459 |   |
|                                                |   |          |     |   |              |   |   |   |
| Marketing contacts                                  |   |          | 0        |   |              |   | 4,187,815 |   |
| Accumulated Amortization                            |   |          | 0        |   |              |   | (4,187,815 | ) |
| Marketing contacts, net of accumulated amortization |   |          | 0        |   |              |   | 0 |   |
|                                                |   |          |     |   |              |   |   |   |
| Total intangibles, net of accumulated amortization  |   | $             | 318,944  |   |              | $      | 344,459 |   |

----

Back to Table of Contents

----

Back to Table of Contents

| For the Year Ended December 31, 2012 |   | For the Six Months Ended June 30, 2013 |       |
|--------------------------------------|--------|----------------------------------------|------------|
|                                 |   | Shares                                 |       |   | Weighted Average Exercise Price |   |   |   | Shares |   |   | Weighted Average Exercise Price |   |
|                                 |   |                                   |       |   |   |   |   |   |   |   |   |   |   |
| Outstanding at beginning of period   |   |                                   | 8,938,668  |   |   | $ | 0.82 |   | Outstanding at beginning of period |   |   | 17,143,468 |   |   | $ | 0.50 |   |
| Granted                              |   |                                   | 8,364,800  |   |   |   | 0.18 |   | Granted |   |   | 900,000 |   |   |   | 0.09 |   |
| Exercised                            |   |                                   | 160,000    |   |   |   | 0.10 |   | Exercised |   |   | 1,539,769 |   |   |   | 0.02 |   |
| Forfeited                            |   |                                   | -          |   |   |   | - |   | Forfeited |   |   | 475,000 |   |   |   | 0.10 |   |
| Expired                              |   |                                   | -          |   |   |   | - |   | Expired |   |   | 375,000 |   |   |   | 1.00 |   |
| Outstanding at end of period         |   |                                   | 17,143,468 |   |   | $ | 0.50 |   | Outstanding at end of period |   |   | 15,653,699 |   |   | $ | 0.39 |   |

|            |         |   | As of June 30, 2013  |   |       | As of June 30, 2013  |   |
|-----------------|--------------|--------|----------------------|--------|------------|----------------------|--------|
|            |         |   | Warrants Outstanding |   |       | Warrants Exercisable |   |
|            |         |   |                 |   |       | Weighted-            |   |   |   |   |   |   |   |   |   |   |
|            |         |   |                 |   |       | Average              |   |   | Weighted- |   |   |   |   |   | Weighted- |   |
| Range of        |         |   | Number               |   |       | Remaining            |   |   | Average |   |   | Number |   |   | Average |   |
| Exercise Prices |         |   | Outstanding          |   |       | Contract Life        |   |   | Exercise Price |   |   | Exercisable |   |   | Exercise Price |   |
|            |         |   |                 |   |       |                 |   |   |   |   |   |   |   |   |   |   |
| $               | 0.075        |   |                 |   | 350,000    |                 |   |   | 4.5 |   |   |   | 0.075 |   |   |   | 350,000 |   |   |   | 0.075 |   |
|            | 0.09         |   |                 |   | 1,125,000  |                 |   |   | 4.9 |   |   |   | 0.09 |   |   |   | 750,000 |   |   |   | 0.09 |   |
|            | 0.15         |   |                 |   | 6,514,800  |                 |   |   | 4.2 |   |   |   | 0.15 |   |   |   | 4,764,800 |   |   |   | 0.15 |   |
|            | 0.25         |   |                 |   | 120,000    |                 |   |   | 2.3 |   |   |   | 0.25 |   |   |   | 120,000 |   |   |   | 0.25 |   |
|            | 0.40         |   |                 |   | 1,299,999  |                 |   |   | 1.7 |   |   |   | 0.40 |   |   |   | 1,299,999 |   |   |   | 0.40 |   |
|            | 0.50         |   |                 |   | 2,614,450  |                 |   |   | 0.9 |   |   |   | 0.50 |   |   |   | 2,614,450 |   |   |   | 0.50 |   |
|            | 0.60         |   |                 |   | 975,000    |                 |   |   | 3.7 |   |   |   | 0.60 |   |   |   | 975,000 |   |   |   | 0.60 |   |
|            | 0.75         |   |                 |   | 120,000    |                 |   |   | 2.3 |   |   |   | 0.75 |   |   |   | 120,000 |   |   |   | 0.75 |   |
|            | 1.00         |   |                 |   | 2,534,450  |                 |   |   | 0.9 |   |   |   | 1.00 |   |   |   | 2,534,450 |   |   |   | 1.00 |   |
| $               | 0.075 - 1.00 |   |                 |   | 15,653,699 |                 |   |   | 2.9 |   |   | $ | 0.39 |   |   |   | 13,528,699 |   |   | $ | 0.43 |   |

----

Back to Table of Contents

| Dividend yield:      | 1%                 |
|----------------------|--------------------|
|                 |               |
| Expectedvolatility   | 283.86% to 549.88% |
|                 |               |
| Riskfreeinterestrate | .31% to 1.41%      |
|                 |               |
| Expectedlife(years)  | 1.00 to 5.00       |

| Balance, December 31, 2011                                         |   | $      | (5,417,525 | )      |
|--------------------------------------------------------------------|--------|--------|------------|--------|
| Change in Fair Value of Warrant Derivative Liability               |   |   | 3,461,614  |   |
| Change in Fair Value of Beneficial Conversion Derivative Liability |   |   | 879,514    |   |
| Change in Fair Value of Debenture Derivative Liability             |   |   | 309,933    |   |
| Adjustments to Warrant Derivative Liability                        |   |   | (1,245,647 | )      |
| Adjustment to Beneficial Conversion Derivative Liability           |   |   | 164,657    |   |
| Adjustment to Debenture Derivative Liability                       |   |   | 510,880    |   |
| Balance, December 31, 2012                                         |   |   | (1,336,574 | )      |
| Change in Fair Value of Warrant Derivative Liability               |   |   | (308,449   | )      |
| Change in Fair Value of Beneficial Conversion Derivative Liability |   |   | 90,421     |   |
| Change in Fair Value of Debenture Derivative Liability             |   |   | 73,607     |   |
| Adjustments to Warrant Derivative Liability                        |   |   | 81,573     |   |
| Adjustment to Beneficial Conversion Derivative Liability           |   |   | (494       | )      |
| Adjustment to Debenture Derivative Liability                       |   |   | 174,140    |   |
| Balance, June 30, 2013                                             |   |   | (1,225,776 | )      |

----

Back to Table of Contents

----

Back to Table of Contents

ITEM

ITEM 4. CONTROLS AND PROCEDURES

----

Back to Table of Contents

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

| (iv)   | To refrain from exercising its rights under the Note through November 15, 2012, which date can, at the Company’s option, be extended an additional 30 days; |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (v)   | To convert $20,000 in principal amount owed under the Note into shares of the Company’s Common Stock, the number of such shares to be determined as set forth in the Forbearance Agreement; and |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (vi)   | To accept as payment in full of the Note (in conjunction with the issuance of the Conversion Shares) a cash payment of $200,000 on or before October 16, 2012 (as such date may be extended at the Company’s option.) |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Back to Table of Contents

ITEM 1A. RISK FACTORS

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

----

Back to Table of Contents

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

ITEM 4. MINE SAFETY DISCLOSURE

ITEM 5. OTHER INFORMATION

----

Back to Table of Contents

ITEM 6. EXHIBITS

| 2.1 | Agreement and Plan of Merger, dated as of September 17, 2009, by and among BioPharma Management Technologies, Inc., a Texas corporation, certain shareholders thereof, Wound Management Technologies, Inc., a Texas corporation, and BIO Acquisition, Inc. (Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed September 21, 2009) |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.1 | Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed April 11, 2008) |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.2 | Articles of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit A to the Company’s Information Statement filed with the Commission on May 13, 2008) |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.3 | Bylaws (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed April 11, 2008) |
|-----|----------------------------------------------------------------------------------------------------------------------------------|

| 10.1 | Manufacturer Exclusive Distributor Agreement dated as of June 21, 2013 by and between Wound Care Innovations, LLC and Academy Medical, LLC (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed July 8, 2013) |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 31.1* | Certification of Principal Executive Officer and Principal Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 302 of the Sarbanes-Oxley Act of 2002* |
|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002* |
|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 101 | Interactive Data Files pursuant to Rule 405 of Regulation S-T. |
|-----|----------------------------------------------------------------|

----

Back to Table of Contents

SIGNATURES

|                  | WOUND MANAGEMENT TECHNOLOGIES, INC. |                                  |
|-----------------------|-------------------------------------|---------------------------------------|
|                  |                                |                                  |   |
| Date: August 12, 2013 | By:                                 | /S/ Robert Lutz, Jr.                  |   |
|                  |                                | Robert Lutz, Jr.,                     |   |
|                  |                                | Chairman of the Board,                |   |
|                  |                                | Chief Executive Officer and President |   |

----